Litcius/Paper detail

Positive and Negative Regulators of Sclerostin Expression

Rina Iwamoto, Masanori Koide, Nobuyuki Udagawa, Yasuhiro Kobayashi

2022International Journal of Molecular Sciences22 citationsDOIOpen Access PDF

Abstract

Sclerostin is secreted from osteocytes, binds to the Wnt co-receptor Lrp5/6, and affects the interaction between Wnt ligands and Lrp5/6, which inhibits Wnt/β-catenin signals and suppresses bone formation. Sclerostin plays an important role in the preservation of bone mass by functioning as a negative regulator of bone formation. A sclerostin deficiency causes sclerosteosis, which is characterized by an excess bone mass with enhanced bone formation in humans and mice. The expression of sclerostin is positively and negatively regulated by many factors, which also govern bone metabolism. Positive and negative regulators of sclerostin expression and their effects are introduced and discussed herein based on recent and previous findings, including our research.

Topics & Concepts

SclerostinWnt signaling pathwayLRP5RegulatorBone remodelingBone formationInternal medicineCell biologyEndocrinologyChemistryReceptorBone massBiologyMedicineSignal transductionOsteoporosisBiochemistryGeneWnt/β-catenin signaling in development and cancerBone Metabolism and DiseasesConnective tissue disorders research
Positive and Negative Regulators of Sclerostin Expression | Litcius